Clinical Trials Directory

Trials / Completed

CompletedNCT02870361

Influence of Central Nervous Insulin Sensitivity on Insulin Secretion

Einfluss Der zentralnervösen Insulinsensitivität Auf Die Insulinsekretion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Insulin resistance is a central pathophysiological component of type 2 diabetes and is associated with a high risk of cardiovascular disease. The tissue in which it manifests are mainly muscle, liver, and adipose tissue. Since the transport of glucose to the brain is independent of insulin, this organ has traditionally not been studied in this regard. In animal experiments, however, knockout of the insulin receptor in the brain leads to obesity and peripheral insulin resistance. This finding of insulin action in the brain could also be confirmed in human studies. The investigators intend to investigate whether central nervous insulin action affects insulin secretion in humans. For this purpose, nasal insulin and placebo are administered 15 minutes before a hyperglycemic hyperinsulinemic clamps, which stimulate insulin secretion. Insulin sensitivity of the brain is measured by a an established protocol with functional magnetic resonance imaging before and after nasal insulin administration.

Conditions

Interventions

TypeNameDescription
DRUGintranasal insulin
DRUGPlacebo

Timeline

Start date
2016-08-01
Primary completion
2018-02-01
Completion
2018-04-01
First posted
2016-08-17
Last updated
2018-05-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02870361. Inclusion in this directory is not an endorsement.

Influence of Central Nervous Insulin Sensitivity on Insulin Secretion (NCT02870361) · Clinical Trials Directory